Biotech stocks have been hit hard — here are ones analysts like best for a rebound
November 08, 2018 at 05:32 AM EST
Nine companies have majority ‘buy’ ratings, with upside potential of as much as 123%, according to analysts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.